Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1G | O43497 | 4/20 | 1.00 |
| ▸ | CACNA1H | O95180 | 4/20 | 1.00 |
| ▸ | TNKS | O95271 | 3/20 | 0.53 |
| ▸ | PARP2 | Q9UGN5 | 3/20 | 0.53 |
| ▸ | PARP1 | P09874 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27194858 | 0.90 | CACNA1G (0.82) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL27194847 | 0.87 | CACNA1G (0.77) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL30079694 | 0.84 | CACNA1G (1.00) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24708724 | 0.84 | CACNA1G (1.00) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL27194859 | 0.83 | CACNA1G (0.71) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24709347 | 0.83 | CACNA1G (0.98) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24709558 | 0.83 | CACNA1G (0.98) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24709104 | 0.83 | CACNA1G (0.98) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24708803 | 0.83 | CACNA1G (0.98) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 | |
| SCHEMBL24709329 | 0.83 | CACNA1G (0.71) | CACNA1GCACNA1HCYP2D6CYP3A4C5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287019-A1 | T-TYPE CALCIUM CHANNEL BLOCKER | FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-4353713-A1 | T-TYPE CALCIUM CHANNEL BLOCKER | Kinki University (JP) | 2024-04-17 | — | — | EP | disclosed |
| WO-2022260016-A1 | T-TYPE CALCIUM CHANNEL BLOCKER | 学校法人近畿大学 | 2022-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287019-A1 | T-TYPE CALCIUM CHANNEL BLOCKER | CACNA1G, CACNA1I, CACNA1H | CACNA1G 1/4885CACNA1H 3/4885TNKS 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.